FindTrial
Sign In

A study about different subgroups of polycystic ovarian syndrome and its relation with anti-mullerian hormone

CORRELATION OF ANTI-MULLERIAN HORMONE IN DIFFERENT SUBGROUPS OF POLYCYSTIC OVARIAN SYNDROME: AN OBSERVATIONAL STUDY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/12/060884
Enrollment
63
Registered
2023-12-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Control Intervention1: nil: nil

Sponsors

Dr Ekta Rani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: women in age group 18 to 39 years coming to OPD with complaints of amenorrhoea/oligomenorrhoea and/or infertility diagnosed as PCOS according to rotterdam criteria

Exclusion criteria

Exclusion criteria: 1) Endocrine diseases other than PCOS that cause ovulation disorders, such as hyperprolactinemia, thyroid disorders, congenital dysfunction of the adrenal cortex, Cushing syndrome and disease, and tumors of the pelvic organs. 2) Pregnancy. 3) A history of using drugs such as insulin sensitizers and oral contraceptives within 3 months. 4) Pre-mature ovarian insufficiency. 5) Total Testosterone > 150 mg/ dl.

Design outcomes

Primary

MeasureTime frame
Correlation of AMH in different subgroups of PCOSTimepoint: 1 year—

Secondary

MeasureTime frame
to find out which of the polycystic ovarian syndrome subgroup has higher AMH levelsTimepoint: 1 year—

Countries

India

Contacts

Public ContactDr Ekta Rani

Rohilkhand Medical College and Hospital

drlataagrawal.la@gmail.com9557033100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026